Last reviewed · How we verify
Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT)
To assess the efficacy and safety of tirofiban administration after intravenous thrombolysis for patients with AIS.
Details
| Lead sponsor | The First Affiliated Hospital of University of Science and Technology of China |
|---|---|
| Phase | PHASE3 |
| Status | COMPLETED |
| Enrolment | 832 |
| Start date | Thu Mar 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Acute Ischemic Stroke
Interventions
- Intravenous thrombolysis plus tirofiban
- Intravenous thrombolysis plus placebo
Countries
China